Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L F Barcellos

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Genes and Immunity|May 23, 2003
Osteopontin polymorphisms and disease course in multiple sclerosisS Caillier, L F Barcellos, S E Baranzini, et al.
Nature Genetics|August 31, 2001
PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patientsL F Barcellos, S Caillier, L Dragone, et al.
Genes and Immunity|June 27, 2008
Genetic variation in nitric oxide synthase 2A (NOS2A) and risk for multiple sclerosisL F Barcellos, P P Ramsay, S J Caillier, et al.
Neurogenetics|November 21, 2001
Linkage and association analysis of chromosome 19q13 in multiple sclerosisM A Pericak-Vance, J B Rimmler, E R Martin, et al.
Brain : a Journal of Neurology|February 9, 2002
Genetic basis for clinical expression in multiple sclerosisL F Barcellos, J R Oksenberg, A J Green, et al.
Genes and Immunity|December 13, 2005
Examination of seven candidate regions for multiple sclerosis: strong evidence of linkage to chromosome 1q44S J Kenealy, L A Herrel, Y Bradford, et al.
Journal of Neuroimmunology|April 20, 2001
Sequence variation in the transforming growth factor-beta1 (TGFB1) gene and multiple sclerosis susceptibilityA J Green, L F Barcellos, J B Rimmler, et al.
Genes and Immunity|January 22, 2010
Supervised machine learning and logistic regression identifies novel epistatic risk factors with PTPN22 for rheumatoid arthritisF B S Briggs, P P Ramsay, E Madden, et al.
Immunogenetics|May 10, 2000
CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics GroupL F Barcellos, A M Schito, J B Rimmler, et al.
American Journal of Human Genetics|January 31, 2003
HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease courseL F Barcellos, J R Oksenberg, A B Begovich, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Genes and Immunity|May 23, 2003
Osteopontin polymorphisms and disease course in multiple sclerosisS Caillier, L F Barcellos, S E Baranzini, et al.
Nature Genetics|August 31, 2001
PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patientsL F Barcellos, S Caillier, L Dragone, et al.
Genes and Immunity|June 27, 2008
Genetic variation in nitric oxide synthase 2A (NOS2A) and risk for multiple sclerosisL F Barcellos, P P Ramsay, S J Caillier, et al.
Neurogenetics|November 21, 2001
Linkage and association analysis of chromosome 19q13 in multiple sclerosisM A Pericak-Vance, J B Rimmler, E R Martin, et al.
Brain : a Journal of Neurology|February 9, 2002
Genetic basis for clinical expression in multiple sclerosisL F Barcellos, J R Oksenberg, A J Green, et al.
Genes and Immunity|December 13, 2005
Examination of seven candidate regions for multiple sclerosis: strong evidence of linkage to chromosome 1q44S J Kenealy, L A Herrel, Y Bradford, et al.
Journal of Neuroimmunology|April 20, 2001
Sequence variation in the transforming growth factor-beta1 (TGFB1) gene and multiple sclerosis susceptibilityA J Green, L F Barcellos, J B Rimmler, et al.
Genes and Immunity|January 22, 2010
Supervised machine learning and logistic regression identifies novel epistatic risk factors with PTPN22 for rheumatoid arthritisF B S Briggs, P P Ramsay, E Madden, et al.
Immunogenetics|May 10, 2000
CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics GroupL F Barcellos, A M Schito, J B Rimmler, et al.
American Journal of Human Genetics|January 31, 2003
HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease courseL F Barcellos, J R Oksenberg, A B Begovich, et al.
Pageof 4